Pregled bibliografske jedinice broj: 538068
Circulating Bone Morphogenetic Protein 1-3 Isoform Increases Renal Fibrosis
Circulating Bone Morphogenetic Protein 1-3 Isoform Increases Renal Fibrosis // Journal of the American Society of Nephrology, 22 (2011), 4; 681-692 doi:10.1681/ASN.2010070722 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 538068 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Circulating Bone Morphogenetic Protein 1-3 Isoform Increases Renal Fibrosis
Autori
Grgurević, Lovorka ; Maček, Boris ; Healy, D.R. ; Brault, A.L. ; Erjavec, Igor ; Čipčić, Antonio ; Grgurević, Ivica ; Rogić, Dunja ; Galešić, Krešo ; Brkljačić, Jelena ; Štern-Padovan, Ranka ; Paralkar, V.M. ; Vukičević, Slobodan
Izvornik
Journal of the American Society of Nephrology (1046-6673) 22
(2011), 4;
681-692
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Growth-factor-beta. Extracellular-matrix accumulation. Human embryonic-development. Tgf-beta. Experimental glomerulonephritis. Gene-expression. Decorin. Kidney. Receptor. Metalloproteinases
Sažetak
Bone morphogenetic proteins (BMPs) participate in organ regeneration through autocrine and paracrine actions, but the existence and effects of these proteins in the systemic circulation is unknown. Using liquid chromatography mass spectrometry, we identified BMP6, GDF15, and the BMP1-3 isoform of the Bmp1 gene in plasma samples from healthy volunteers and patients with CKD. We isolated the endogenous BMP1-3 protein and demonstrated that it circulates as an active enzyme, evidenced by its ability to cleave dentin matrix protein-1 in vitro. In rats with CKD, administration of recombinant BMP1-3 increased renal fibrosis and reduced survival. In contrast, administration of a BMP1-3-neutralizing antibody reduced renal fibrosis, preserved renal function, and increased survival. In addition, treating with the neutralizing antibody was associated with low plasma levels of TGF beta 1 and connective tissue growth factor. In HEK293 cells and remnant kidneys, BMP1-3 increased the transcription of collagen type I, TGF beta 1, beta-catenin, and BMP7 via a BMP- and Wnt-independent mechanism that involved signaling through an integrin 01 subunit. The profibrotic effect of BMP1-3 may, in part, be a result of the accompanied decrease in decorin (DCN) expression. Taken together, inhibition of circulating BMP1-3 reduces renal fibrosis, suggesting that this pathway may be a therapeutic target for CKD.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti, Farmacija
POVEZANOST RADA
Projekti:
108-1080327-0320 - Uloga TSH u modelu osteoporoze i u bolesnica sa smanjenom koštanom masom (Vukičević, Slobodan, MZOS ) ( CroRIS)
108-1081872-1908 - Dijagnostika i liječenje limfoma (Aurer, Igor, MZOS ) ( CroRIS)
198-0000000-0179 - Prognostički čimbenici progresije bubrežne insuficijencije (Galešić, Krešimir, MZOS ) ( CroRIS)
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Medicinski fakultet, Zagreb,
Klinička bolnica "Dubrava",
Klinički bolnički centar Zagreb
Profili:
Dunja Rogić
(autor)
Slobodan Vukičević
(autor)
Jelena Brkljačić
(autor)
Ivica Grgurević
(autor)
Ranka Štern-Padovan
(autor)
Igor Erjavec
(autor)
Lovorka Grgurević
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE